
Promising Response to Neoadjuvant Chemotherapy Plus Immunotherapy in Metaplastic Breast Carcinoma
Introduction Metaplastic breast carcinoma (MpBC) is a rare and aggressive subtype of breast cancer, accounting for less than 1% of all invasive breast malignancies.1–3 It comprises various histological subtypes, including squamous cell carcinoma, …